Drug Susceptibility and Genetic Evaluation of Plasmodium Falciparum Isolates Obtained in Four Distinct Geographical Regions of Kenya

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 2004 Aug 26

PMID 15328137

Citations 20

Authors

Abigael Mbaisi

Pamela Liyala

Fredrick Eyase

Rachel Achilla

Hosea Akala

Julia Wangui

Josphat Mwangi

Finnley Osuna

Uzma Alam

Bonnie L Smoak

Jon M Davis

Dennis E Kyle

Rodney L Coldren

Carl Mason

Norman C Waters

Affiliations

Soon will be listed here.

Abstract

The drug resistance profiles of Plasmodium falciparum isolated from four regions in Kenya were analyzed for drug resistance profiles. We observed variability in resistance to a broad range of antimalarial drugs across Kenya as determined from in vitro drug susceptibility screening and genotyping analysis.

Citing Articles

Increased sensitivity of malaria parasites to common antimalaria drugs after the introduction of artemether-lumefantrine: Implication of policy change and implementation of more effective drugs in fight against malaria.

Okore W, Ouma C, Okoth R, Yeda R, Ingasia L, Mwakio E PLoS One. 2024; 19(6):e0298585.

PMID: 38900782 PMC: 11189199. DOI: 10.1371/journal.pone.0298585.

The Walter Reed Project, Kisumu Field Station: Impact of Research on Malaria Policy, Management, and Prevention.

Sifuna P, Mbinji M, Lucas T, Onyango I, Akala H, Waitumbi J Am J Trop Med Hyg. 2024; 110(6):1069-1079.

PMID: 38653233 PMC: 11154051. DOI: 10.4269/ajtmh.23-0115.

In vitro activity of rhinacanthin analogues against drug resistant Plasmodium falciparum isolates from Northeast Thailand.

Chaorattanakawee S, Kosaisavee V, Bunsermyos W, Aonsri C, Imaram W, Suwannasin K Malar J. 2023; 22(1):105.

PMID: 36959593 PMC: 10035203. DOI: 10.1186/s12936-023-04532-3.

Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009-2011: a randomized controlled trial and brief review.

Lek D, Rachmat A, Harrison D, Chin G, Chaoratanakawee S, Saunders D Malar J. 2022; 21(1):259.

PMID: 36071520 PMC: 9450427. DOI: 10.1186/s12936-022-04279-3.

The Multistage Antimalarial Compound Calxinin Perturbates Ca Homeostasis by Targeting a Unique Ion Channel.

Gupta Y, Sharma N, Singh S, Romero J, Rajendran V, Mogire R Pharmaceutics. 2022; 14(7).

PMID: 35890267 PMC: 9319510. DOI: 10.3390/pharmaceutics14071371.

References

Sibley C, Hyde J, Sims P, Plowe C, Kublin J, Mberu E . Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?. Trends Parasitol. 2002; 17(12):582-8. DOI: 10.1016/s1471-4922(01)02085-2. View

Wellems T, Plowe C . Chloroquine-resistant malaria. J Infect Dis. 2001; 184(6):770-6. DOI: 10.1086/322858. View

Kublin J, Dzinjalamala F, Kamwendo D, Malkin E, Cortese J, Martino L . Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002; 185(3):380-8. DOI: 10.1086/338566. View

Wongsrichanalai C, PicKard A, Wernsdorfer W, Meshnick S . Epidemiology of drug-resistant malaria. Lancet Infect Dis. 2002; 2(4):209-18. DOI: 10.1016/s1473-3099(02)00239-6. View

Sidhu A, Verdier-Pinard D, Fidock D . Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science. 2002; 298(5591):210-3. PMC: 2954758. DOI: 10.1126/science.1074045. View

Sulo J, Chimpeni P, Hatcher J, Kublin J, Plowe C, Molyneux M . Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial. Lancet. 2002; 360(9340):1136-43. DOI: 10.1016/s0140-6736(02)11198-6. View

Mberu E, Nzila A, Nduati E, Ross A, Monks S, Kokwaro G . Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance. Exp Parasitol. 2002; 101(2-3):90-6. DOI: 10.1016/s0014-4894(02)00108-x. View

Curtis J, Maxwell C, Msuya F, Mkongewa S, Alloueche A, Warhurst D . Mutations in dhfr in Plasmodium falciparum infections selected by chlorproguanil-dapsone treatment. J Infect Dis. 2002; 186(12):1861-4. DOI: 10.1086/345765. View

Lang T, Greenwood B . The development of Lapdap, an affordable new treatment for malaria. Lancet Infect Dis. 2003; 3(3):162-8. DOI: 10.1016/s1473-3099(03)00547-4. View

10.

Bousema J, Gouagna L, Meutstege A, Okech B, Akim N, Githure J . Treatment failure of pyrimethamine-sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western Kenya. Trop Med Int Health. 2003; 8(5):427-30. DOI: 10.1046/j.1365-3156.2003.01047.x. View

11.

Kublin J, Cortese J, Njunju E, Mukadam R, Wirima J, Kazembe P . Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis. 2003; 187(12):1870-5. DOI: 10.1086/375419. View

12.

Price R, Cassar C, Brockman A, Duraisingh M, van Vugt M, White N . The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob Agents Chemother. 1999; 43(12):2943-9. PMC: 89592. DOI: 10.1128/AAC.43.12.2943. View

13.

Verhoef H, Hodgins E, Eggelte T, Carter J, Lema O, West C . Anti-malarial drug use among preschool children in an area of seasonal malaria transmission in Kenya. Am J Trop Med Hyg. 1999; 61(5):770-5. DOI: 10.4269/ajtmh.1999.61.770. View

14.

Khalil I, Ronn A, Alifrangis M, Gabar H, Satti G, Bygbjerg I . Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole. Am J Trop Med Hyg. 2003; 68(5):586-9. DOI: 10.4269/ajtmh.2003.68.586. View

15.

SPENCER H, Masaba S, Kiaraho D . Sensitivity of Plasmodium falciparum isolates to chloroquine in Kisumu and Malindi, Kenya. Am J Trop Med Hyg. 1982; 31(5):902-6. DOI: 10.4269/ajtmh.1982.31.902. View

16.

Webster H, Boudreau E, Pavanand K, Yongvanitchit K, Pang L . Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method. Am J Trop Med Hyg. 1985; 34(2):228-35. DOI: 10.4269/ajtmh.1985.34.228. View

17.

Wilson C, Serrano A, Wasley A, Bogenschutz M, Shankar A, Wirth D . Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science. 1989; 244(4909):1184-6. DOI: 10.1126/science.2658061. View

18.

Foote S, Thompson J, Cowman A, Kemp D . Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell. 1989; 57(6):921-30. DOI: 10.1016/0092-8674(89)90330-9. View

19.

Foote S, Galatis D, Cowman A . Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci U S A. 1990; 87(8):3014-7. PMC: 53824. DOI: 10.1073/pnas.87.8.3014. View

20.

Peterson D, Milhous W, Wellems T . Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci U S A. 1990; 87(8):3018-22. PMC: 53825. DOI: 10.1073/pnas.87.8.3018. View